Description
Based on the AREDS2* study, MacuHealthPLUS+ is formulated by eye health experts for patients diagnosed with age-related macular degeneration (AMD). The evidence base for supplementation in patients with AMD favors an AREDS2* formulation, but without dangerous levels of Zinc, and using a supplement that contains all three macular carotenoids in a MZ:L:Z (mg) ratio of 10:10:2. The only such commercially available supplement is MacuHealthPLUS+.
Now with patented Micro-Micelle™ Technology, MacuHealthPLUS+ delivers statistically significant increases in carotenoid concentrations and the highest level of bioavailability studied to date.
